Blueprint Medicines Corp (BPMC) stock is lower by -27.54% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives BPMC stock a score of 24 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 4. BPMC's rank also includes a long-term technical score of 18. The fundamental score for BPMC is 50. In addition to the average rating from Wall Street analysts, BPMC stock has a mean target price of $113.33. This means analysts expect the stock to add 52.82% over the next 12 months.
BPMC has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on BPMC!
Blueprint Medicines Corp (BPMC) stock has risen 1.38% while the S&P 500 is lower by -0.18% as of 2:41 PM on Wednesday, Jan 19. BPMC is higher by $1.01 from the previous closing price of $73.15 on volume of 193,367 shares. Over the past year the S&P 500 has gained 20.26% while BPMC is lower by -27.54%. BPMC lost -$7.10 per share in the over the last 12 months.
Click Here to get the full Stock Report for Blueprint Medicines Corp stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
